|
Most Recent Releases
|
|
Date
|
Title
(click to view the full text) |
|
11/2/2009
|
Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2010
|
|
10/28/2009
|
Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2010 on November 2, 2009
|
|
10/1/2009
|
Array BioPharma to Present Clinical Results on Diabetes Drug at European Diabetes Meeting
|
|
9/18/2009
|
Array BioPharma Enters into Equity Distribution Agreement
|
|
9/15/2009
|
Array BioPharma to Present at the UBS Global Life Sciences Conference
|
|
9/3/2009
|
Array BioPharma Announces Top-Line Results from Rheumatoid Arthritis Phase 2 Trial
|
|
9/2/2009
|
Array BioPharma to Present at the Baird 2009 Healthcare Conference and the Thomas Weisel Partners 2009 Healthcare Conference
|
|
8/10/2009
|
Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2009
|
|
8/10/2009
|
Array BioPharma Reports Positive Results of Its Oral Glucokinase Activator in Type 2 Diabetes Patients
|
|
8/5/2009
|
Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2009 on August 10, 2009
|
|
7/15/2009
|
Array BioPharma Advances Its Lead MEK Inhibitor into Cancer
|
|
7/8/2009
|
Array BioPharma Announces Top-Line Results in Two Phase 1 Clinical Trials
|
|
6/11/2009
|
Array BioPharma to Present at the Jefferies 3rd Annual Healthcare Conference
|
|
6/2/2009
|
Array BioPharma Recognized by CIO Magazine as One of the CIO 100 Award Honorees
|
|
5/19/2009
|
Array BioPharma Receives Additional $40 Million Funding Commitment
|
|
5/12/2009
|
Array BioPharma to Present at Leerink Swann Oncology Roundtable Conference
|
|
5/4/2009
|
Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2009
|
|
4/29/2009
|
Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2009 on May 4, 2009
|
|
4/21/2009
|
Array BioPharma Presents Initial Data on Novel Class of Chk1 Inhibitors
|
|
4/21/2009
|
Array BioPharma's ARRY-520 Demonstrates Significant Activity in Hematological and Taxane-Resistant Tumors
|
|
4/21/2009
|
Array BioPharma's ARRY-543 Shows Potential Clinical Benefit in Cancer Patients
|
|
4/19/2009
|
Array BioPharma's ARRY-614 Demonstrates Cytokine Inhibition and Anti-Tumor Activity in Preclinical Models of Hematological Cancers
|
|
4/8/2009
|
Array BioPharma Initiates Clinical Trial in Type 2 Diabetic Patients
|
|
4/6/2009
|
Array BioPharma Announces Eighteen Abstracts Selected for Presentation at 2009 AACR Annual Meeting
|
|
3/3/2009
|
Array BioPharma to Present at the Barclays Capital Global HealthCare Conference
|
|
2/2/2009
|
Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2009
|
|
2/2/2009
|
Array BioPharma to Present at the BIO CEO & Investor Conference
|
|
1/26/2009
|
Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2009 on February 2, 2009
|
|
1/9/2009
|
Array BioPharma Initiates Phase 1 Clinical Trial for MEK Inhibitor ARRY-300
|
|
1/9/2009
|
Array BioPharma Accelerates Partnering Activities and Scales Back Discovery Research to Extend Available Capital
|
|
12/23/2008
|
Array BioPharma Receives $40 Million from Deerfield
|
|
12/16/2008
|
Array BioPharma to Present at the JP Morgan 27th Annual Healthcare Conference
|
|
11/20/2008
|
Array BioPharma to Present at the Piper Jaffray Health Care Conference
|
|
11/7/2008
|
Array BioPharma Inc. Files Shelf Registration Statement
|
|
11/3/2008
|
Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2009
|
|
10/27/2008
|
Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2009 on November 3, 2008
|
|
10/26/2008
|
Array BioPharma's Oral p38 Inhibitor Demonstrates Significant Analgesic Benefit and Systemic Anti-Inflammatory Activity
|
|
10/20/2008
|
Array BioPharma to Present Clinical Data at the 2008 ACR/ARHP Annual Scientific Meeting
|
|
9/29/2008
|
Array BioPharma to Present at the William Blair Small-Cap Growth Stock Conference
|
|
9/25/2008
|
Array BioPharma Presents Positive Preclinical Data on Its Glucokinase Activators in Type 2 Diabetes
|
|
9/16/2008
|
Array BioPharma to Present at the UBS Global Life Sciences Conference
|
|
9/2/2008
|
Array BioPharma to Present at the Morgan Stanley Global Healthcare Unplugged Conference and the Baird Small Cap Healthcare Conference
|
|
8/27/2008
|
Array BioPharma to Present at the Thomas Weisel Partners 2008 Healthcare Conference
|
|
8/11/2008
|
Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2008
|
|
7/30/2008
|
Array BioPharma to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
|
|
7/28/2008
|
Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2008 on August 11, 2008
|
|
6/30/2008
|
Array BioPharma to Present at the Collins Stewart 4th Annual Growth Conference
|
|
6/16/2008
|
Array BioPharma to Present at the Jefferies 2nd Annual Healthcare Conference
|
|
6/12/2008
|
Array BioPharma Presents Additional Positive Phase 1 Results in Two Programs at the 2008 Annual European Congress of Rheumatology
|
|
6/10/2008
|
Array BioPharma to Present Clinical Data at the 2008 Annual European Congress of Rheumatology
|
|
6/9/2008
|
Array BioPharma to Present at the Jefferies 2nd Annual Healthcare Conference
|
|
5/16/2008
|
Array BioPharma to Present at the Citi 2008 Global Healthcare Conference
|
|
5/15/2008
|
Array BioPharma and AstraZeneca Announce New Phase 2 Development Plans for the Investigational Anti-Cancer Drug AZD6244 (ARRY-886)
|
|
5/8/2008
|
Array BioPharma to Present at the Bank of America Securities Healthcare Conference
|
|
5/7/2008
|
Array BioPharma Presents Additional Positive Phase 2 Results in Inflammatory Pain Clinical Trial at the American Pain Society's Annual Scientific Meeting
|
|
5/5/2008
|
Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2008
|
|
5/5/2008
|
Array BioPharma Receives $80 Million Funding Commitment
|
|
5/5/2008
|
Array BioPharma to Present at Leerink Swann Conference
|
|
4/30/2008
|
Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2008 on May 5, 2008
|
|
3/25/2008
|
Array BioPharma Advances p38 / Tie2 Inhibitor, ARRY-614, into Phase 1 Clinical Trial
|
|
3/18/2008
|
Array BioPharma Names Gary M. Clark, Ph.D., Vice President, Biostatistics and Data Management
|
|
3/13/2008
|
Array BioPharma to Present at the Lehman Brothers Global Healthcare Conference
|
|
3/3/2008
|
Array BioPharma to Present at the Susquehanna Healthcare Conference
|
|
3/3/2008
|
Array BioPharma Announces Positive Phase 2 Top-Line Results in Inflammatory Pain Clinical Trial
|
|
2/6/2008
|
Array BioPharma to Present at the 2008 BIO CEO & Investor Conference
|
|
2/4/2008
|
Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2008
|
|
1/31/2008
|
Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2008 on February 4, 2008
|
|
1/3/2008
|
Array BioPharma to Present at the 26th Annual JPMorgan Healthcare Conference
|
|
12/19/2007
|
Topline Results Announced from a Phase 2 Study in Advanced Melonoma of Investigational Anti-Cancer Drug AZD6244 (ARRY-886)
|
|
11/20/2007
|
Array BioPharma to Present at the 19th Annual Piper Jaffray Health Care Conference
|
|
11/20/2007
|
Array BioPharma Advances p38 Inhibitor, ARRY-797, into Phase 2 Clinical Trial
|
|
11/5/2007
|
Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2008
|
|
10/31/2007
|
Array BioPharma to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
|
|
10/31/2007
|
Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2008 on November 5, 2007
|
|
10/24/2007
|
Array BioPharma Reports Positive New Data on ErbB-2 / EGFR Inhibitor, ARRY-543
|
|
10/22/2007
|
Array BioPharma to Present Clinical Data at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
|
|
9/24/2007
|
Array BioPharma and Celgene Corporation Announce Strategic Global R&D Collaboration
|
|
9/17/2007
|
Array BioPharma to Present at the UBS Global Life Sciences Conference
|
|
8/29/2007
|
Array BioPharma to Present at the Thomas Weisel Partners Healthcare Conference
|
|
8/6/2007
|
Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2007
|
|
8/3/2007
|
Array BioPharma Advances ErbB-2 Inhibitor, ARRY-380, into Phase 1 Cancer Patient Trial
|
|
8/2/2007
|
Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2007 on August 6, 2007
|
|
7/5/2007
|
Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
|
|
6/21/2007
|
Array BioPharma to Present at the Jefferies Healthcare Conference
|
|
6/20/2007
|
Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
|
|
6/6/2007
|
Array BioPharma to Present at the Needham Biotechnology & Medical Technology Conference
|
|
5/30/2007
|
Array BioPharma to Present Clinical Data at the European League Against Rheumatism (EULAR) Annual Meeting and the 8th World Congress on Inflammation
|
|
5/23/2007
|
Array BioPharma to Present at the Banc of America Securities Healthcare Conference
|
|
5/15/2007
|
Array BioPharma Appoints John Yates, MB ChB, MD, to Chief Medical Officer
|
|
5/8/2007
|
Array BioPharma Appoints Dr. Jonathan Kay to Its Scientific Advisory Board for Inflammation Therapy
|
|
5/3/2007
|
Array BioPharma Initiates Phase 1 Clinical Trial for Anticancer KSP Inhibitor ARRY-520
|
|
5/1/2007
|
Array BioPharma Inc. Announces Pricing of Proposed Public Offering of Common Stock
|
|
4/23/2007
|
Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2007
|
|
4/23/2007
|
Array BioPharma Inc. Announces Proposed Public Offering of Common Stock
|
|
4/18/2007
|
Array BioPharma Appoints Dr. Neil Spector to Its Scientific Advisory Board
|
|
4/12/2007
|
Array BioPharma Achieves Milestone for Dosing MEK Inhibitor, ARRY-704, in Phase 1 Clinical Trial
|
|
4/10/2007
|
Array BioPharma Advances p38 Inhibitor, ARRY-797, into Phase 1 Cancer Patient Trial
|
|
3/14/2007
|
Array BioPharma to Present at the Lehman Brothers Annual Global Healthcare Conference
|
|
3/13/2007
|
Array BioPharma and VentiRx Pharmaceuticals Announce License Agreement
|
|
2/6/2007
|
Array BioPharma to Present at the BIO CEO & Investor Conference
|
|
2/5/2007
|
Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2007
|
|
1/30/2007
|
Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2007 on February 5, 2007
|
|
12/28/2006
|
Array BioPharma's KSP Inhibitor for Cancer to Advance into Human Clinical Trials
|
|
12/22/2006
|
Array BioPharma to Present at the 25th Annual JPMorgan Healthcare Conference
|
|
11/28/2006
|
Array BioPharma Announces Analyst Event and Live Webcast in New York City
|
|
11/21/2006
|
Array BioPharma to Present at the Piper Jaffray Health Care Conference
|
|
11/8/2006
|
Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers: phase II trials initiated
|
|
11/6/2006
|
Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2007
|
|
11/6/2006
|
Array BioPharma Announces Clinical Trial Data With AZD6244 (ARRY-142886) To Be Presented at the 2006 EORTC-NCI-AACR International Meeting
|
|
10/31/2006
|
Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2007 on November 6, 2006
|
|
10/31/2006
|
Array BioPharma's p38 Inhibitor for Inflammatory Disease to Advance into Human Clinical Trials
|
|
10/23/2006
|
Array BioPharma to Present at the C.E. Unterberg, Towbin Life Sciences Conference
|
|
10/19/2006
|
Array BioPharma Reports MEK Inhibitor, ARRY-438162, Meets Initial Clinical Objectives
|
|
10/6/2006
|
Array BioPharma Inc. Files Shelf Registration Statement
|
|
10/3/2006
|
Array BioPharma to Present Inflammation Pipeline at the 14th International IRA Conference
|
|
9/14/2006
|
Array BioPharma Receives Phase 2 Milestone Payment From AstraZeneca
|
|
9/14/2006
|
Array BioPharma to Present at the UBS Global Life Sciences Conference
|
|
9/14/2006
|
Array BioPharma to Present at the Leerink Swann & Company Cancer Medicines on the Horizon Conference
|
|
8/28/2006
|
Array BioPharma to Present at the Roth Capital Partners 2006 New York Conference
|
|
8/28/2006
|
Array BioPharma to Present at the Thomas Weisel Partners Healthcare Conference
|
|
8/10/2006
|
Array BioPharma Receives $14 Million From Longmont Facilities Transaction
|
|
8/7/2006
|
Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2006
|
|
8/1/2006
|
Array BioPharma to Present at the 26th Annual Canaccord Adams Summer Seminar
|
|
7/31/2006
|
Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2006 on August 7, 2006
|
|
7/11/2006
|
Array BioPharma Receives $18 Million From Boulder Facilities Transaction
|
|
7/6/2006
|
Array BioPharma to Present at the C.E. Unterberg, Towbin Emerging Growth Conference
|
|
6/22/2006
|
Array BioPharma to Obtain $32 Million in Additional Cash From Facilities Transactions
|
|
6/20/2006
|
Array BioPharma to Present at the Jefferies Life Sciences Conference
|
|
6/8/2006
|
AstraZeneca and Array BioPharma Announce Initiation of Phase II Studies for AZD6244 (ARRY-142886)
|
|
6/5/2006
|
Array BioPharma to Present at the Needham Annual Biotechnology & Medical Technology Conference
|
|
5/1/2006
|
Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2006
|
|
4/26/2006
|
Array BioPharma Initiates Phase 1 Clinical Trial of Its MEK Inhibitor for Inflammatory Disease
|
|
4/25/2006
|
Array Biopharma to Report Financial Results for the Third Quarter of Fiscal 2006 on May 1, 2006
|
|
4/17/2006
|
Array BioPharma Achieves Research Milestone in Genentech Collaboration
|
|
4/10/2006
|
Array BioPharma Achieves Milestone for Selection of Third Compound for MEK Anti-Cancer Program
|
|
3/14/2006
|
Array BioPharma Announces KSP Anti-Cancer Program
|
|
2/8/2006
|
Array BioPharma to Present at the Roth Capital Partners Annual Growth Stock Conference
|
|
2/6/2006
|
Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2006
|
|
2/1/2006
|
Array BioPharma to Present at the BIO CEO & Investor Conference 2006
|
|
1/30/2006
|
Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2006 on February 6, 2006
|
|
1/24/2006
|
Array BioPharma Achieves Milestone for Selection of Second Clinical Candidate for MEK Anti-Cancer Program
|
|
1/17/2006
|
Array BioPharma Initiates Phase I Clinical Trial for Targeted Anticancer Drug ARRY-334543
|
|
12/13/2005
|
Co-Founder of Array BioPharma to Lead New Korean Out-Sourcing Chemistry Company
|
|
11/8/2005
|
Array BioPharma to Present Phase IA Data From Anti-Cancer Compound at the AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics
|
|
11/3/2005
|
Array BioPharma Announces Drug Discovery Collaboration With Ono Pharmaceutical Co., Ltd.
|
|
10/31/2005
|
Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2006
|
|
10/24/2005
|
Array BioPharma to Report Financial Results for the First Quarter Fiscal 2006 on October 31, 2005
|
|
10/13/2005
|
Array BioPharma and Genentech Expand Strategic Oncology Collaboration
|
|
9/19/2005
|
Array BioPharma to Present at the UBS Global Life Sciences Conference
|
|
8/31/2005
|
Array BioPharma to Present at the Thomas Weisel Partners Healthcare Conference 2005
|
|
8/8/2005
|
Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2005
|
|
8/8/2005
|
Array BioPharma's Anticancer Compound ARRY-334543 Cleared to Advance Into Human Clinical Trials
|
|
8/5/2005
|
Array BioPharma Amends Facility Lease
|
|
8/4/2005
|
Array BioPharma Announces Lease Restatement
|
|
8/3/2005
|
Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2005 on August 8, 2005
|
|
7/19/2005
|
InterMune and Array BioPharma Expand Hepatitis C Drug Discovery Collaboration
|
|
5/18/2005
|
Array BioPharma to Present at the Fourth Annual Needham Biotechnology Conference
|
|
5/12/2005
|
Array BioPharma to Present Data From Anti-Cancer Program at the American Society of Clinical Oncology Annual Meeting
|
|
5/10/2005
|
Array BioPharma Receives Milestone Payment From Amgen
|
|
5/9/2005
|
Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2005
|
|
5/4/2005
|
Array BioPharma to Present at the Banc of America Securities Health Care Conference 2005
|
|
5/2/2005
|
Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2005 on May 9, 2005
|
|
4/18/2005
|
Array BioPharma Presents Data on Two Cancer Programs at the 96th Annual Meeting of the American Association for Cancer Research
|
|
4/7/2005
|
Array BioPharma and Genentech Expand Oncology Collaboration
|
|
2/15/2005
|
Array BioPharma to Present at the BIO CEO & Investor Conference 2005
|
|
2/8/2005
|
Reminder - Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2005 on February 7, 2005
|
|
2/7/2005
|
Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2005
|
|
1/31/2005
|
Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2005 on February 7, 2005
|
|
1/18/2005
|
Array BioPharma to Present at the Piper Jaffray Health Care Conference
|
|
2002 Press Releases
|
|
Date
|
Title
(click to view the full text) |
|
12/19/2002
|
Array BioPharma Adjusts Growth Expectations for Fiscal 2003
|
|
11/4/2002
|
Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2003
|
|
10/31/2002
|
Array BioPharma Appoints Gil Van Lunsen From KPMG to Its Board of Directors
|
|
10/28/2002
|
Array BioPharma To Report Financial Results for the First Quarter of Fiscal 2003 On November 4, 2002
|
|
9/30/2002
|
InterMune and Array BioPharma Announce Drug Discovery Collaboration Focused on Hepatitis
|
|
9/23/2002
|
Array CEO Robert E. Conway to Speak At UBS Warburg Global Life Sciences Conference
|
|
8/5/2002
|
Array BioPharma Reports Financial Results For The Fourth Quarter and Full Year of Fiscal 2002
|
|
7/30/2002
|
Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2002 On August 5, 2002
|
|
5/22/2002
|
Array CEO Robert E. Conway to Speak At Needham & Company Biotechnology Conference
|
|
5/14/2002
|
Array BioPharma Appoints James D. Winkler, Ph.D. Discovery Biology Director
|
|
5/13/2002
|
Array BioPharma Added to Nasdaq Biotechnology Index
|
|
5/6/2002
|
Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2002
|
|
5/1/2002
|
Array BioPharma Appoints John R. Moore General Counsel
|
|
4/26/2002
|
Array CEO Robert E. Conway to Speak at Deutsche Bank Securities Health Care Conference
|
|
4/25/2002
|
Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2002 on May 6, 2002
|
|
4/22/2002
|
Callisto, Array BioPharma In Collaboration
|
|
4/5/2002
|
Aptus and Array BioPharma Announce Drug Discovery Collaboration; Small Molecule Drug Discovery Agreement Targets GPCRs
|
|
3/13/2002
|
Array BioPharma Announces Drug Discovery Collaboration With Japan Tobacco
|
|
2/27/2002
|
Array BioPharma Announces Exercise of Over-Allotment Option in Public Offering
|
|
2/19/2002
|
Array CEO Robert E. Conway to Speak At Bio CEO & Investor Conference and Lehman Brothers Healthcare Conference
|
|
2/19/2002
|
Array BioPharma to Expand Laboratory Space
|
|
2/14/2002
|
Array BioPharma Schedules Conference Call to Provide Financial Guidance
|
|
2/13/2002
|
Array BioPharma Announces Pricing of Stock Offering
|
|
1/22/2002
|
Array BioPharma Reports Financial Results For The Second Quarter of Fiscal 2002
|
|
1/18/2002
|
Array BioPharma to Report Financial Results For The Second Quarter of Fiscal 2002 on January 22, 2002
|
|
1/16/2002
|
Array BioPharma Files Registration Statement For Public Offering of Common Stock
|
|
1/15/2002
|
Array BioPharma Announces Compound Acquisition Agreements With Pfizer
|
|
1/14/2002
|
Array BioPharma Initiates a New Drug Discovery Program With Amgen
|
